Go to the list of all blogs
M. Benett's Avatar
published in Blogs
Aug 04, 2026
GlobalFoundries (GFS): Can the Stock Return to $80 for +60% Upside?

GlobalFoundries (GFS): Can the Stock Return to $80 for +60% Upside?

Key Takeaways

  • Price Target: The $80 level represents the consensus analyst price target for GlobalFoundries (NASDAQ: GFS) — roughly 60% above the stock's recent close near $50, and a level the stock previously surpassed during its May 2026 rally to $92.55.
  • Strongest Bullish Factors: Growing AI-driven demand for mature-node chips, the $300 million CHIPS Act R&D award for silicon photonics, a recent acquisition of Synopsys' Processor IP Solutions business, and a consistent track record of earnings beats provide a solid fundamental foundation.
  • Biggest Risks: A sharp 46% decline from the 52-week high signals fragile investor confidence; Morgan Stanley just lowered its target to $57; Q2 earnings guidance points to a potential sequential profit decline; and smartphone market weakness remains a headwind.
  • Key Levels: Support sits near the 52-week low of $31.51, while resistance looms at the May 2026 breakdown zone around $65–$70. A sustained move above $60 would mark the first technical sign of recovery.
  • Bottom Line: Returning to $80 is plausible but not imminent. It likely requires a meaningful reacceleration in revenue growth, stabilization in the smartphone segment, and tangible evidence that AI-related tailwinds are translating into earnings power.

Why the $80 Level Draws Investor Attention

The $80 price point has become a focal point for GFS investors because it sits squarely at the intersection of Wall Street consensus and recent market memory. The average 12-month analyst price target across 21 firms tracked by TipRanks stands at approximately $80.31, with firms like Needham, Loop Capital, and Cantor Fitzgerald explicitly setting $80 targets. Meanwhile, the stock traded as high as $92.55 in late May 2026 before a punishing summer selloff erased roughly 46% of its value — meaning $80 is not merely an aspirational round number but a level the market has already priced in the recent past. I also checked comparable names using Tickeron’s AI Screener to see how GFS stacks up against peers in the sector.

Company Overview

GlobalFoundries is one of the world's top-five contract semiconductor manufacturers, originally spun out of AMD in 2009. Headquartered in Malta, New York, the company operates fabrication facilities across the United States, Germany, and Singapore. Unlike TSMC or Intel, GlobalFoundries does not compete at the bleeding edge of semiconductor process technology. Instead, it has carved out a strategically valuable niche in mature, specialized process nodes — including FD-SOI, RF-SOI, and power management platforms — that serve automotive, industrial IoT, aerospace and defense, communications infrastructure, and data center markets. The company holds a "Trusted Foundry" designation with the U.S. federal government, underscoring its role in securing critical domestic semiconductor supply chains. Majority-owned by Mubadala Investment Company, the UAE sovereign wealth fund, GlobalFoundries generated approximately $6.75 billion in revenue in 2024 and employs roughly 13,000 people worldwide.

Current Market Position

As of the August 3, 2026, close, GFS shares settled at $50.01, near the lower end of a 52-week range spanning $31.51 to $92.55. The stock carries a trailing price-to-earnings (P/E) ratio of approximately 35.7 and a forward P/E near 25.4, with a market capitalization of roughly $27.5 billion. The company has demonstrated consistent earnings execution, beating consensus estimates in each of the last four quarters — most recently delivering Q1 2026 adjusted earnings per share (EPS) of $0.40 against a $0.35 expectation on revenue of $1.63 billion. However, the Q2 2026 guidance calling for adjusted EPS of $0.25–$0.35 and revenue of approximately $1.76 billion pointed to potential sequential margin compression, which contributed to the stock's steep decline. The next earnings report, scheduled for August 5, 2026, before market open, represents a critical near-term catalyst. From what I see, reviewing the technical setup with Tickeron’s AI Trend Prediction Engine added useful context on potential near-term moves.

Factors That Could Push Shares Higher

Several structural tailwinds support the bull case for GFS returning to $80. First, the company's strategic emphasis on mature-node chip manufacturing positions it to benefit from the AI buildout without requiring the extreme capital intensity of leading-edge fabrication. AI infrastructure demands a wide range of power management, connectivity, and sensor chips — precisely the specialty areas where GlobalFoundries excels. Second, the recently signed $300 million CHIPS Act R&D award focused on silicon photonics for AI applications validates the company's technological roadmap and strengthens its balance sheet. Third, the acquisition of Synopsys' Processor IP Solutions business expands GlobalFoundries' reach into automotive, industrial robotics, and edge AI. Fourth, the launch of Quantum Technology Solutions signals long-term ambitions in high-performance computing. Finally, the SCALE optical module solution for co-packaged optics directly addresses the bandwidth bottlenecks facing AI data centers.

Challenges Standing in the Way

Significant obstacles stand between the current $50 share price and the $80 target. Morgan Stanley's recent downgrade of its price target to $57 — just above current levels — reflects skepticism about near-term growth durability. Bank of America Securities maintains a rare Sell rating with a $65 target. The smartphone market, a meaningful end market for GlobalFoundries' RF and connectivity chips, continues to face demand headwinds. Customer concentration risk remains elevated, with a limited number of large clients accounting for a substantial portion of revenue. Additionally, the stock's beta of 1.76 makes it roughly 76% more volatile than the broader market, meaning any macroeconomic deterioration or semiconductor sector rotation could trigger outsized declines. The massive drawdown from $92.55 to $50 also suggests that bullish narratives around AI tailwinds have not yet translated into sustained investor conviction.

Analyst Views and Price Targets

The analyst community presents a divided picture. Of 22 analysts covering GFS, approximately 9 rate it Strong Buy, 3 rate it Buy, 9 rate it Hold, and 1 rates it Sell. The consensus average target of approximately $80 implies roughly 60% upside from current levels. The most bullish voice comes from Susquehanna, which maintains a Positive rating and a $125 target — more than double the current price. Evercore ISI and TD Cowen each hold $85 targets with Buy-equivalent ratings. On the cautious side, Morgan Stanley's $57 Equal Weight target and BofA's $65 Sell rating reflect concerns that the stock's AI narrative has outpaced its fundamental execution. This wide dispersion — from $57 to $125 — underscores genuine uncertainty about GlobalFoundries' growth trajectory in an increasingly competitive semiconductor landscape.

Important Technical Levels to Watch

From a technical perspective, GFS has carved out a clear downtrend since peaking at $92.55 in May 2026. The $60 level represents a psychologically important threshold — reclaiming it would mark the first significant higher low in months and potentially attract momentum-driven buyers. The $65–$70 zone aligns with several analyst targets from the cautious camp and also corresponds to a prior support area that has now flipped to resistance. A decisive break above $70 would put the $80 target within striking distance on a technical basis. On the downside, the 52-week low of $31.51 serves as the ultimate support floor, though intermediate buying interest could emerge near $45, a level that previously acted as support during early 2026 consolidation.

Final Assessment

The question of whether GlobalFoundries can reach $80 again is fundamentally a question about whether the company can re-establish the growth narrative that propelled shares to $92.55 earlier this year. The structural case remains intact: mature-node semiconductor demand tied to AI infrastructure, automotive electrification, and industrial automation provides a multi-year runway. The CHIPS Act funding and recent strategic acquisitions add tangible catalysts. However, the stock's severe correction from its highs signals that the market now demands proof, not promises. The August 5 earnings report represents a near-term inflection point — if management can demonstrate that AI-related revenue streams are accelerating and that smartphone weakness is stabilizing, a path back toward $80 becomes considerably more credible. Conversely, another quarter of tepid guidance would reinforce the cautious narrative and likely keep resistance levels firmly intact. Investors should monitor revenue growth trends, gross margin trajectory, and any commentary about customer diversification as the key variables that will determine whether the $80 target is achievable in the coming quarters.

Enhancing Research with Tickeron Tools

In my analysis of volatile names like GFS, I often rely on Tickeron’s AI Daily Buy/Sell Signals to cut through conflicting signals and spot potential shifts more efficiently. The platform uses AI to scan thousands of stocks in real time and deliver actionable Buy, Sell, or Hold guidance based on technical patterns, which helps complement traditional research when navigating sector swings between optimism and caution.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: GFS

Momentum Indicator for GFS turns positive, indicating new upward trend

GFS saw its Momentum Indicator move above the 0 level on September 17, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 96 similar instances where the indicator turned positive. In 77 of the 96 cases, the stock moved higher in the following days. The odds of a move higher are at 80%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where GFS's RSI Oscillator exited the oversold zone, 23 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.

Following a +5.96% 3-day Advance, the price is estimated to grow further. Considering data from situations where GFS advanced for three days, in 224 of 295 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GFS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.

GFS broke above its upper Bollinger Band on September 18, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for GFS entered a downward trend on September 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 25 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 45 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.190) is normal, around the industry mean (8.017). P/E Ratio (36.266) is within average values for comparable stocks, (160.839). Projected Growth (PEG Ratio) (0.697) is also within normal values, averaging (3.725). Dividend Yield (0.005) settles around the average of (0.006) among similar stocks. P/S Ratio (3.464) is also within normal values, averaging (44.558).

The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating fairly steady price growth. GFS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GFS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock worse than average.

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Taiwan Semiconductor Manufacturing Company Ltd (NYSE:TSM), Broadcom Inc. (NASDAQ:AVGO), Micron Technology (NASDAQ:MU), Advanced Micro Devices (NASDAQ:AMD), Intel Corp (NASDAQ:INTC), Texas Instruments (NASDAQ:TXN), Marvell Technology (NASDAQ:MRVL), QUALCOMM (NASDAQ:QCOM), Analog Devices (NASDAQ:ADI).

Industry description

The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.

Market Cap

The average market capitalization across the Semiconductors Industry is 215.64B. The market cap for tickers in the group ranges from 86.8K to 5.49T. NVDA holds the highest valuation in this group at 5.49T. The lowest valued company is STRB at 86.8K.

High and low price notable news

The average weekly price growth across all stocks in the Semiconductors Industry was 6%. For the same Industry, the average monthly price growth was 6%, and the average quarterly price growth was 61%. ARM experienced the highest price growth at 36%, while MOBX experienced the biggest fall at -15%.

Volume

The average weekly volume growth across all stocks in the Semiconductors Industry was -15%. For the same stocks of the Industry, the average monthly volume growth was -11% and the average quarterly volume growth was -55%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 53
Price Growth Rating: 44
SMR Rating: 72
Profit Risk Rating: 72
Seasonality Score: -20 (-100 ... +100)
View a ticker or compare two or three
GFS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Semiconductors

Industry
N/A
Address
400 Stonebreak Road Extension
Phone
+1 518 305-9013
Employees
14000
Web
https://www.gf.com
Interact to see
Advertisement
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.